These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
392 related items for PubMed ID: 17581166
1. Do patients with autoantibodies or clinically insignificant alloantibodies require an indirect antiglobulin test crossmatch? Lee E, Redman M, Burgess G, Win N. Transfusion; 2007 Jul; 47(7):1290-5. PubMed ID: 17581166 [Abstract] [Full Text] [Related]
2. Electronic crossmatching. Arslan O. Transfus Med Rev; 2006 Jan; 20(1):75-9. PubMed ID: 16373190 [Abstract] [Full Text] [Related]
3. Indirect antiglobulin test-crossmatch using low-ionic-strength saline-albumin enhancement medium and reduced incubation time: effectiveness in the detection of most clinically significant antibodies and impact on blood utilization. Dinardo CL, Bonifácio SL, Mendrone A. Immunohematology; 2014 Jan; 30(1):1-5. PubMed ID: 25238242 [Abstract] [Full Text] [Related]
4. RISK OF RED BLOOD CELL ALLOIMMUNISATION IN RWANDA: ASSESSMENT OF PRETRANSFUSION CROSSMATCH TECHNIQUES USED IN DISTRICT HOSPITALS. Ndahimana E, Gothot A, Gérard C, Senyana F, R'Zik S, Mukabayire O, Mutesa L. East Afr Med J; 2013 Apr; 90(4):124-9. PubMed ID: 26866096 [Abstract] [Full Text] [Related]
10. Cut-off value of red-blood-cell-bound IgG for the diagnosis of Coombs-negative autoimmune hemolytic anemia. Kamesaki T, Oyamada T, Omine M, Ozawa K, Kajii E. Am J Hematol; 2009 Feb; 84(2):98-101. PubMed ID: 19105232 [Abstract] [Full Text] [Related]
11. [3 new antibody detection tests. A comparative study]. Mempel W, Alraun K, Leeping M, Kirschner M, Reiser H, Heim MU. Beitr Infusionsther; 1990 Feb; 26():362-6. PubMed ID: 1703872 [Abstract] [Full Text] [Related]
12. Frequency of delayed hemolytic transfusion reactions following antibody screening and immediate-spin crossmatching. Pinkerton PH, Coovadia AS, Goldstein J. Transfusion; 1992 Feb; 32(9):814-7. PubMed ID: 1471244 [Abstract] [Full Text] [Related]
14. The risk of an overt hemolytic transfusion reaction following the use of an immediate spin crossmatch. Shulman IA. Arch Pathol Lab Med; 1990 Apr; 114(4):412-4. PubMed ID: 2322101 [Abstract] [Full Text] [Related]
15. [Flow cytometry analysis of IGG subclasses of auto- and alloantibodies in autoimmune hemolytic anemia and hemolytic disease of the newborn]. Lynen R, Neuhaus R, Simson G, Riggert J, Köhler M. Beitr Infusionsther Transfusionsmed; 1994 Apr; 32():203-7. PubMed ID: 9480088 [Abstract] [Full Text] [Related]
17. Problems associated with compatibility testing for patients with autoimmune hemolytic anemia. Garratty G. Southeast Asian J Trop Med Public Health; 1993 Apr; 24 Suppl 1():76-9. PubMed ID: 7886613 [Abstract] [Full Text] [Related]
18. Safety in transfusion practice. Is it safe to eliminate the major crossmatch for selected patients? Shulman IA, Kent D. Arch Pathol Lab Med; 1989 Mar; 113(3):270-2. PubMed ID: 2919957 [Abstract] [Full Text] [Related]
20. Pathology consultation on electronic crossmatch. Mazepa MA, Raval JS, Park YA, Education Committee of the Academy of Clinical Laboratory Physicians and Scientists. Am J Clin Pathol; 2014 May; 141(5):618-24. PubMed ID: 24713731 [Abstract] [Full Text] [Related] Page: [Next] [New Search]